<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE341nnn/GSE341979/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Homo sapiens</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE341979</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>GPX3 suppresses lung adenocarcinoma progression through HSPB1 ubiquitination and Hippo pathway activation</name><description>Lung adenocarcinoma (LUAD) is the most common subtype of lung cancer; however, its prognosis remains poor, and the underlying molecular mechanisms have yet to be fully elucidated. In this study, a prognostic model was constructed based on manganese metabolism-related genes, which effectively stratifies LUAD patients with different prognoses and drug sensitivity. Mendelian randomization analysis identified glutathione peroxidase 3 (GPX3) as a key prognostic gene, which was downregulated in LUAD and significantly correlated with favorable outcomes.</description><dates><publication>2026/07/30</publication></dates><accession>GSE341979</accession><cross_references><GSM>GSM9921179</GSM><GSM>GSM9921178</GSM><GSM>GSM9921177</GSM><GSM>GSM9921176</GSM><GSM>GSM9921175</GSM><GSM>GSM9921174</GSM><GPL>34284</GPL><GSE>341979</GSE><taxon>Homo sapiens</taxon></cross_references></HashMap>